Within the tumor microenvironment (TME), the early stages are characterized by a predominance of M1 macrophages, NK cells, and CD4+/CD8 + T cells, which secrete anti-tumor factors including IL-2, IL-12, IL-18, and IFN-γ (41, 42). This evidence concerns the gene IL2 and neoplasm.